PegBio (HKG:2565) applied to the China Securities Regulatory Commission to convert over 101.7 million unlisted shares held by 20 shareholders into Hong Kong-listed shares, a Friday filing with the Hong Kong bourse said.
The shares represent roughly 26.35% of the biopharmaceutical company's issued share capital.
The firm will make announcements regarding the Hong Kong-listed share full circulation as and when needed.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments